Evidence map›Paper›PMID 42346447›Full record

ArticleJournal of cardiovascular development and disease2026

Risk Stratification of Adverse Outcomes After Heart Transplantation with the 2022 Definition of Pulmonary Hypertension.

Mattia Corianò, Nicola Pradegan, Francesco Putortì, Arianna Calonaci, Andrea Golfetto, Vincenzo Tarzia, Annalisa Angelini, Chiara Tessari, Marny Fedrigo, Giuseppe Toscano and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of cardiovascular development and disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Mattia CorianòCardiology Unit, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua, 35100 Padua, Italy.ORCID 0000-0002-4583-280X
Nicola PradeganCardiac Surgery Unit, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua, 35100 Padua, Italy.ORCID 0000-0002-5129-5190
Francesco PutortìCardiology Unit, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua, 35100 Padua, Italy.ORCID 0009-0006-4830-0354
Arianna CalonaciCardiology Unit, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua, 35100 Padua, Italy.
Andrea GolfettoCardiology Unit, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua, 35100 Padua, Italy.
Vincenzo TarziaCardiac Surgery Unit, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua, 35100 Padua, Italy.
Annalisa AngeliniPathology and Pathological Anatomy Unit, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, 35100 Padova, Italy.ORCID 0000-0002-3578-4488
Chiara TessariCardiac Surgery Unit, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua, 35100 Padua, Italy.ORCID 0000-0001-9011-1625
Marny FedrigoCardiovascular Pathology, Department of Integrated Diagnostic Services, Hospital-University of Padua, 35128 Padua, Italy.ORCID 0000-0002-3081-2937
Giuseppe ToscanoCardiac Surgery Unit, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua, 35100 Padua, Italy.
Gino GerosaCardiac Surgery Unit, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua, 35100 Padua, Italy.ORCID 0000-0002-6261-699X
Francesco TonaCardiology Unit, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua, 35100 Padua, Italy.ORCID 0000-0003-4828-7875

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pulmonary hypertension (PH) is associated with adverse outcomes after heart transplantation (HT). In 2022, the European Society of Cardiology introduced lower thresholds for pulmonary vascular resistance (PVR) to distinguish isolated post-capillary PH (IpcPH) and combined post-capillary PH (CpcPH). We conducted a single-center retrospective study on 357 patients who underwent HT between 1985 and 2020 and had right heart catheterization prior to transplant, investigating the ability of the new PVR threshold to predict one-year mortality. Overall, 65 patients had no PH, 84 had IpcPH, and 208 had CpcPH. One-year survival was higher in patients without PH and similar between IpcPH and CpcPH (

Indexed as

heart transplantationpulmonary hypertensionpulmonary resistance

Identifiers

PMID42346447
PMCPMC13301771

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.